Free Trial

Lantern Pharma (LTRN) Insider Trading & Ownership

-0.07 (-1.29%)
(As of 06/14/2024 ET)

Lantern Pharma (NASDAQ:LTRN) Insider Buying and Selling Activity

Insider Ownership
Number Of
Insiders Buying
(Last 12 Months)
Number Of
Insiders Selling
(Last 12 Months)
Amount Of
Insider Selling
(Last 12 Months)
$1.17 M
Get LTRN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lantern Pharma stock? Sign up for's daily newsletter to get the latest insider transactions delivered to your inbox daily.

LTRN Insider Buying and Selling by Quarter

Lantern Pharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/23/2024Aaron G.L. FletcherMajor ShareholderSell10,000$6.25$62,500.00  
2/28/2024Aaron G.L. FletcherMajor ShareholderSell74,297$4.85$360,340.45  
1/17/2024Aaron G.L. FletcherMajor ShareholderSell58,889$4.20$247,333.80  
11/29/2023Leslie W KreisMajor ShareholderSell145,348$3.44$499,997.12  
(Data available from 1/1/2013 forward)

LTRN Insider Trading Activity - Frequently Asked Questions

Who is on Lantern Pharma's Insider Roster?

The list of insiders at Lantern Pharma includes Aaron G.L. Fletcher, and Leslie W Kreis. Learn more on insiders at LTRN.

What percentage of Lantern Pharma stock is owned by insiders?

6.92% of Lantern Pharma stock is owned by insiders. Learn more on LTRN's insider holdings.

Which Lantern Pharma insiders have been selling company stock?

The following insiders have sold LTRN shares in the last 24 months: Aaron G.L. Fletcher ($670,174.25), and Leslie W Kreis ($2,039,997.12).

How much insider selling is happening at Lantern Pharma?

Insiders have sold a total of 638,534 Lantern Pharma shares in the last 24 months for a total of $2,710,171.37 sold.

More Insider Trading Tools from MarketBeat

This page (NASDAQ:LTRN) was last updated on 6/14/2024 by Staff

From Our Partners